Alteration of Diffusion-Tensor Magnetic Resonance Imaging Measures in Brain Regions Involved in Early Stages of Parkinson's Disease
暂无分享,去创建一个
Ying-Hui Chou | Nan-Kuei Chen | Mark Sundman | Patrick Hickey | Willard S Kasoff | Adam Bernstein | Theodore P Trouard | Tanya Lin | Steven Z Rapcsak | Scott J Sherman | Carol P Weingarten | S. Rapcsak | S. Sherman | T. Trouard | N. Chen | M. Sundman | Y. Chou | W. Kasoff | C. P. Weingarten | A. Bernstein | Tanya P Lin | Patrick Hickey
[1] Dorothee P. Auer,et al. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis☆ , 2013, NeuroImage: Clinical.
[2] S. Daniel,et al. The anterior olfactory nucleus in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.
[3] J. Fisk,et al. Lateralized microstructural changes in early-stage Parkinson’s disease in anterior olfactory structures, but not in substantia nigra , 2017, Journal of Neurology.
[4] J. Molinuevo,et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study , 2013, The Lancet Neurology.
[5] Ali Bilgin,et al. A diffusion-matched principal component analysis (DM-PCA) based two-channel denoising procedure for high-resolution diffusion-weighted MRI , 2018, PloS one.
[6] Paul M. Matthews,et al. MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study , 2009, NeuroImage.
[7] Felix C. Morency,et al. A test-retest study on Parkinson's PPMI dataset yields statistically significant white matter fascicles , 2017, NeuroImage: Clinical.
[8] D. Wesson,et al. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases , 2016, Neurobiology of Disease.
[9] Stamatios N. Sotiropoulos,et al. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging , 2016, NeuroImage.
[10] Thomas Hummel,et al. Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT , 2004, Movement disorders : official journal of the Movement Disorder Society.
[11] Klaus P. Ebmeier,et al. Diffusion tensor imaging in parkinsonian syndromes , 2013, Neurology.
[12] R. Barker,et al. Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases , 2017, Parkinsonism & related disorders.
[13] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[14] C. Scherfler,et al. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease , 2011, Journal of Neurology.
[15] Hyunjin Park,et al. Using Tractography to Distinguish SWEDD from Parkinson's Disease Patients Based on Connectivity , 2016, Parkinson's disease.
[16] H. Braak,et al. Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology , 2016, Neuropathology and applied neurobiology.
[17] Dorothee P. Auer,et al. The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T , 2014, PloS one.
[18] Habib Benali,et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease , 2013, Brain : a journal of neurology.
[19] L. Tan,et al. White matter microstructural characteristics in newly diagnosed Parkinson’s disease: An unbiased whole-brain study , 2016, Scientific Reports.
[20] S. Daniel,et al. Commentary Qjm Is Parkinson's Disease a Primary Olfactory Disorder? , 2022 .
[21] Michael Schocke,et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: A diffusion‐tensor imaging and voxel‐based morphometry study , 2011, Annals of neurology.
[22] P. Basser,et al. MR diffusion tensor spectroscopy and imaging. , 1994, Biophysical journal.
[23] Y Ben-Shlomo,et al. How valid is the clinical diagnosis of Parkinson's disease in the community? , 2002, Journal of neurology, neurosurgery, and psychiatry.
[24] Ming Shao,et al. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. , 2014, European journal of radiology.
[25] Richard L. Doty,et al. Presence of both odor identification and detection deficits in alzheimer's disease , 1987, Brain Research Bulletin.
[26] W. Oertel,et al. Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[27] O. Abe,et al. A preliminary diffusional kurtosis imaging study of Parkinson disease: comparison with conventional diffusion tensor imaging , 2014, Neuroradiology.
[28] H. Braak,et al. 100 years of Lewy pathology , 2013, Nature Reviews Neurology.
[29] Daniel Rueckert,et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.
[30] Randy L. Gollub,et al. Reproducibility of quantitative tractography methods applied to cerebral white matter , 2007, NeuroImage.
[31] P. Basser,et al. Diffusion tensor MR imaging of the human brain. , 1996, Radiology.
[32] J. Allen,et al. Differentiating Non-Motor Symptoms in Parkinson's Disease from Controls and Hemifacial Spasm , 2013, PloS one.
[33] E. Larsson,et al. Olfactory Impairment in Parkinson’s Disease Studied with Diffusion Tensor and Magnetization Transfer Imaging , 2017, Journal of Parkinson's disease.
[34] E. Tolosa,et al. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel‐based diffusion tensor imaging study , 2010, Movement disorders : official journal of the Movement Disorder Society.
[35] P. Svenningsson,et al. Diffusion tensor fiber tractography of the olfactory tract. , 2011, Magnetic resonance imaging.
[36] R. Doty. Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? , 2017, The Lancet Neurology.
[37] R. Doty,et al. Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.
[38] F. Valldeoriola,et al. Brain correlates of progressive olfactory loss in Parkinson's disease. , 2017, Parkinsonism & related disorders.
[39] Yoshimi Anzai,et al. Loss of Olfactory Tract Integrity Affects Cortical Metabolism in the Brain and Olfactory Regions in Aging and Mild Cognitive Impairment , 2013, The Journal of Nuclear Medicine.
[40] R. Doty. Olfaction in Parkinson's disease. , 2007, Parkinsonism & related disorders.
[41] O. Coulon,et al. Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis , 2017, NeuroImage: Clinical.
[42] David E. J. Linden,et al. Increased fractional anisotropy in the motor tracts of Parkinson's disease suggests compensatory neuroplasticity or selective neurodegeneration , 2016, European Radiology.